Centessa Pharmaceuticals to Participate in Upcoming Investor Conferences
30 October 2023 - 11:00PM
Centessa Pharmaceuticals plc (Nasdaq: CNTA), a clinical-stage
pharmaceutical company that aims to discover and develop
transformational medicines for patients, today announced that
members of its management team will participate in the following
investor conferences:
Event: Jefferies London Healthcare
ConferenceDate: November 15,
2023Location: LondonFireside
Chat: 10:30 AM BST
Event: Evercore ISI 6th Annual HealthCONx
ConferenceDate: November 28,
2023Location: Miami, FLFireside
Chat: 4:40 PM ET
Access to the live webcasts of these events, as well as archived
recordings, will be available under the “Events and Publications”
tab on the investor relations section of the Centessa
Pharmaceuticals website at
https://investors.centessa.com/events-presentations.
About Centessa
Pharmaceuticals Centessa Pharmaceuticals plc is a
clinical-stage pharmaceutical company that aims to discover and
develop transformational medicines for patients. Our programs span
discovery-stage to late-stage development and cover a range of
high-value indications in rare diseases and immuno-oncology. We
operate with the conviction that each one of our programs has the
potential to change the current treatment paradigm and establish a
new standard of care. For more information, visit www.centessa.com,
which does not form part of this release.
Contact:Kristen K. Sheppard, Esq.SVP of
Investor Relationsinvestors@centessa.com
Centessa Pharmaceuticals (NASDAQ:CNTA)
Historical Stock Chart
From May 2024 to Jun 2024
Centessa Pharmaceuticals (NASDAQ:CNTA)
Historical Stock Chart
From Jun 2023 to Jun 2024